C12Y 302/01075
Glucan endo-1,6-beta-glucosidase
Official title: Glucan endo-1,6-beta-glucosidase (3.2.1.75)
C12Y302/01075 (Glucan endo-1,6-beta-glucosidase) appears on 15 US grants and 16 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 16
- Assignees
- 12
- Inventors
- 56
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 2 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Processes for producing fermentation products and compositions used therein15 Apr 2025US 12,275,967 B2Novozymes A/S
- β-1, 6-glucanase mutant, and method for measuring β-1, 6-glucan25 Oct 2022US 11,479,803 B2Toei Shinyaku Co., Ltd.
- β-1,3-1,6-endoglucanase producing, from β-glucan, oligosaccharides or glucose28 Jul 2020US 10,724,061 B2Korea University Research and Business Foundation
- Cellulose and/or hemicelluloses degrading enzymes from Macrophomina phaseolina and uses thereof19 Sep 2017US 9,765,315 B2Bangladesh Jute Research Institute
- Rhodanobacter ginsenosidimutans KCTC22231T-derived ginsenoside glycosidase, and use thereof4 Nov 2014US 8,877,463 B2Korea Research Institute of Bioscience and Biotechnology
- Polypeptides having beta-glucanase activity and polynucleotides encoding same3 Jul 2025US 2025/0215409 A1Novozymes A/S
- Methods of administering genetically modified b cells for in vivo delivery of therapeutic agents28 Dec 2023US 2023/0414659 A1
- Polypeptides having beta-glucanase activity and polynucleotides encoding same19 Jan 2023US 2023/0012672 A1Novozymes A/S
- ?-1,6-glucanase mutant, and method for measuring ?-1,6-glucan27 May 2021US 2021/0155970 A1Toei Shinyaku Co., Ltd.
- Antigen treatment method21 Jan 2021US 2021/0017564 A1Sekisui Medical Co., Ltd.
Most cited
By later US patents
- Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof40US 6,569,661 B1Biomarin Pharmaceutical Inc. · 2003
- Method for improving the solubility of vegetable proteins39US 5,989,600 ANovo Nordisk A/S · 1999
- Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase38US 6,858,206 B22005
- Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof24US 6,426,208 B1Harbor-UCLA Research and Education Institute · 2002
- Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof20US 6,585,971 B1Harbor-UCLA Research and Education Institute · 2003